Quantitative sense-specific determination of murine coronavirus RNA by reverse transcription polymerase chain reaction

Journal of Virological Methods

Volumn 78, Issue 1-2, 1999, Pages 35-49

  Schoenike, Barry ^a,b   Franta, Amy K ^a,b   Fleming, John O ^a,b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b WILLIAM S MIDDLETON MEMORIAL VETERANS HOSPITAL   (United States)

Author keywords

Coronaviruses; Mouse hepatitis virus; PCR; Sense specific RNA determination

Indexed keywords

VIRUS RNA;

ACCURACY; ARTICLE; CORONAVIRUS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA SEQUENCE; SEQUENCE HOMOLOGY; TECHNIQUE; TEMPERATURE;

ANIMALS; CORONAVIRUS INFECTIONS; DNA, ANTISENSE; MALE; MICE; MICE, INBRED C57BL; MURINE HEPATITIS VIRUS; PLASMIDS; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, ANTISENSE; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; TRANSCRIPTION, GENETIC;

CORONAVIRUS; MURINAE; MURINE HEPATITIS VIRUS; MURINE HEPATITIS VIRUS STRAIN 4;

EID: 0032977675     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-0934(98)00167-0     Document Type: Article

References (36)

1. Ausubel, F.M., Brent, R., Kingston, R.E., Moore, D.D., Seidman, J.G., Smith, J.A., Struhl, K. (Eds.), 1994. Current Protocols in Molecular Biology, Wiley, New York, pp. 4.9.12.
2. Bauer P., Rolfs A., Regitz-Zagrosek V., Hildebrandt A., Fleck E. Use of maganese in RT-PCR eliminates PCR artifacts resulting from DNase I digestion. BioTechniques. 22:1997;1128-1132.
3. Blumberg D.D. Creating a ribonuclease-free environment. Methods Enzymol. 152:1987;20-24.
4. Busch M.P., Wilber J.C., Johnson P., Tobler L., Evans C.S. Impact of specimen handling and storage on detection of hepatitis C virus RNA. Transfusion. 32:1992;420-425.
5. Chaves R.L., Graff J., Normann A., Flehmig B. Specific detection of minus strand hepatitis A virus RNA by Tail-PCR following reverse transcription. Nucleic Acids Res. 22:1994;1919-1920.
6. Cheley S., Anderson R., Cupples M.J., Lee Chan E.C.M., Morris V.L. Intracellular murine hepatitis virus-specific RNAs contain common sequences. Virology. 112:1981;596-604.
7. Chou Q., Russell M., Birch D., Raymond J., Bloch W. Prevention of pre-PCR mis-priming and primer dimerization improves low-copy-number amplifications. Nucleic Acids Res. 20:1992;1717-1723.
8. Farkas D.H., Kaul K.L., Wiedbrauk D.C., Kiechle F.L. Specimen collection and storage for diagnostic molecular pathology investigation. Arch. Pathol. Lab. Med. 120:1996;591-596.
9. Fleming J.O., Trousdale M.D., El-Zaatari F.A.K., Stohlman S.A., Weiner L.P. Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies. J. Virol. 58:1986;869-875.
10. Foley K.P., Leonard M.W., Engel J.D. Quantitation of RNA using the polymerase chain reaction. Trends Genet. 9:1993;380-385.
11. Gill S.S., Aubin R.A., Bura C.A., Curran I.H.A., Matula T.I. Ensuring recovery of intact RNA from rat pancreas. Mol. Biotech. 6:1996;359-362.
12. Gilland G., Perrin S., Bunn H.F. Competitive PCR for quantitation of mRNA. Innis M.A., Gelfand D.H., Sninsky J.J., White T.J. PCR Protocols. 1990;60-69 Academic Press, San Diego.
13. Gunji T., Kato N., Hijikata M., Hayashi K., Saitoh S., Shimotohno K. Specific detection of positive and negative stranded hepatitis C viral RNA using chemical RNA modification. Arch. Virol. 134:1994;293-302.
14. Halfon P., Khiri H., Gerolami V., Bourliere M., Feryn J.M., Reynier P., Gauthier A., Cartouzou G. Impact of various handling and storage conditions on quantitative detection of hepatitis C virus RNA. J. Hepatol. 25:1996;307-311.
15. Ho S.N., Hunt H.D., Horton R.M., Pullen J.K., Pease L.R. Site directed mutagenesis by overlap extension using the polymerase chain reaction. Gene. 77:1989;51-59.
16. Hofmann M.A., Sethna P.B., Brian D.A. Bovine coronavirus mRNA replication continues throughout persistent infection in cell culture. J. Virol. 64:1990;4108-4114.
17. Horton R.M., Hunt H.D., Ho S.N., Pullen J.K., Peace L.R. Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene. 77:1989;61-68.
18. Houtman J.J., Fleming J.O. Pathogenesis of mouse hepatitis virus-induced demyelination. J. NeuroVirol. 2:1996;361-376.
19. Jagus R. Hybrid selection of mRNA and hybrid arrest of translation. Methods Enzymol. 152:1987;567572.
20. Köhler, T., Lassner, D., Rost, A.-K., Thamm, B., Pustowoit, B., Remke, H. (Eds.), 1995. Quantification of mRNA by Polymerase Chain Reaction, Springer, Berlin.
21. Lai M.M.C., Cavanagh D. The molecular biology of coronaviruses. Adv. Virus Res. 48:1997;1-100.
22. Lanford R.E., Sureau C., Jacob J.R., White R., Fuerst T.R. Demonstration of in vitro infection of chimpanzee hepatocytes with hepatitis C virus using strand-specific RT-PCR. Virology. 202:1994;606-614.
23. Lerat H., Berby F., Traubaud M-A., Vidalin O., Major M., Trépo C., Inchauspé G. Specific detection of hepatitis C virus minus strand RNA in hematopoietic cells. J. Clin. Invest. 97:1996;845-851.
24. McGuinness P.H., Bishop G.A., McCaughan G.W., Trowbridge R., Gowans E.J. False detection of negative-strand hepatitis C virus RNA. Lancet. 343:1994;551-552.
25. Mullis K. The polymerase chain reaction in an anemic mode: how to avoid cold oligodeoxyribonuclear fusion. PCR Methods Appl. 1:1991;1-4.
26. Prediger E. RNA isolation: new ways to handle tissue and store RNA. Ambion TechNotes. 5:1998;1-16.
27. Rock R.C. Technical evaluation of laboratory studies. Noe D.A., Rock R.C. Laboratory Medicine: The Selection and Interpretation of Clinical Laboratory Studies. 1994;15-26 Williams and Wilkins, Baltimore.
28. Saag M.S. Quantification of HIV viral load: a tool for clinical practice. Sande M.A., Volberding P.A. The Medical Management of AIDS. 1997;57-74 W.B. Saunders, Philadelphia.
29. Schneeberger C., Speiser P., Kury F., Zeillinger R. Quantitative detection of reverse transcriptase-PCR products by means of a novel and sensitive DNA stain. PCR Methods Appl. 4:1995;234-238.
30. Silver J., Limjoco T., Feinstone S. Site-specific mutagenesis using the polymerase chain reaction. Innis M.A., Gelfand D.H., Sninsky J.J. PCR Strategies. 1995;179-188 Academic Press, San Diego.
31. Tsai S-J., Wiltbank M.C. Quantification of mRNA using competitive RT-PCR with standard curve methodology. BioTechniques. 21:1996;862-866.
32. Wang A.M., Doyle M.V., Mark D.F. Quantitation of mRNA by the polymerase chain reaction. Proc. Natl. Acad. Sci. USA. 86:1989;9717-9721.
33. Wang F.I., Fleming J.O., Lai M.M.C. Sequence analysis of the spike protein gene of murine coronavirus variants: study of genetic sites affecting neuropathogenicity. Virology. 186:1992;742-749.
34. Willems M., Moshage H., Yap S.H. PCR and detection of negative HCV RNA strands. Hepatology. 17:1993;526.
35. Yokoi H., Natsuyama S., Iwai M., Noda Y., Mori T., Mori K.J., Fujita K., Nakayama H., Fujita J. Non-radioisotopic quantitative RT-PCR to detect changes in mRNA levels during early mouse embryo development. Biochem. Biophys. Res. Commun. 195:1993;769-775.
36. Zazzi M., Romano L., Peruzzi F., Toneatto S., De Milito A., Botta G., Valensin P.E. Optimal conditions for detection of human immunodeficiency virus type 1 DNA by polymerase chain reaction with nested primers. Mol. Cell. Probes. 7:1993;431-437.